• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    High 0.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVSMD
Vasamed Inc
10.0
0.0x
---
United StatesADLI
American Medical Technologies Inc
10.0
0.0x
---
United StatesAVTI
Avitar Inc
130.0
0.0x
---
United StatesOMRX
Orthometrix Inc
5.3K
0.0x
---
United StatesHMGN
Hemagen Diagnostics Inc
20.0
0.0x
---
United StatesDECN
Decision Diagnostics Corp
140.0
0.0x
---
As of 2024-11-22

Company Information

Vasamed Incorporated designs, licenses, manufactures and distributes products, software and services for assessing and managing hemodynamic health. Its SensiLase peripheral arterial disease (PAD)-IQ Studycast System provides measurement of tissue perfusion of the extremities particularly in patients with combined peripheral arterial disease and diabetes. The SensiLase PAD-IQ Studycast supports non-invasive upper and lower extremity vascular assessments, including skin perfusion pressure microcirculation pulse volume recording and ankle brachial index (ABI) calculation for doppler-obtained pressures; data sorting and customization options to support database mining, and wound imaging and surface area calculation featuring SmartDraw. SensiLase PAD-IQ System featuring Studycast Data Management offers health professionals various support tools for both PAD and critical limb ischemia. Its AcQtrac System technology is designed to measure cardiac and hemodynamic parameters.

Contact Information

Headquarters
7615 Golden Triangle DrMINNEAPOLIS, MN, United States 55344-3733
Phone
952-944-5837
Fax
952-944-6022

Executives

President and Chief Executive Officer and Director
Paulita LaPlante
Chief Financial Officer, Vice President - Finance and Administration
Roberta Dircks
Vice President - Operations
Kent Winger
Vice President of Sales and Marketing
Terry Duesterhoeft
Director
Richard Egen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$10.00
Revenue (TTM)
$3.4M
Shares Outstanding
8.0M
Vasamed Inc does not pay a dividend.
Beta
---
EPS
$-0.24
Book Value
$-0.15
P/E Ratio
0.0x
Price/Sales (TTM)
0.0
Price/Cash Flow (TTM)
---
Operating Margin
-47.25%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.